Revolution Medicines annual revenue
2018
2019
2020
2021
2022
2023
2024
2025
Revolution Medicines Revenue Growth & History (RVMD)
Revolution Medicines reported $0 in revenue for fiscal 2025.
View full Revolution Medicines company overviewRevolution Medicines annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | −$11.6M | −100.00% |
| 2023 | 2023-12-31 | $11.6M | −$23.8M | −67.27% |
| 2022 | 2022-12-31 | $35.4M | $6.0M | +20.38% |
| 2021 | 2021-12-31 | $29.4M | −$13.6M | −31.62% |
| 2020 | 2020-12-31 | $43.0M | −$7.1M | −14.10% |
| 2019 | 2019-12-31 | $50.0M | $29.9M | +148.16% |
| 2018 | 2018-12-31 | $20.2M | — | — |
Revolution Medicines quarterly revenue
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | — | — |
| Q4 2025 | 2025-12-31 | $0 | $0 | — |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $0 | $0 | — |
| Q4 2024 | 2024-12-31 | $0 | −$742,000 | −100.00% |
| Q3 2024 | 2024-09-30 | $0 | $0 | — |
| Q2 2024 | 2024-06-30 | $0 | −$3.8M | −100.00% |
| Q1 2024 | 2024-03-31 | $0 | −$7.0M | −100.00% |
| Q4 2023 | 2023-12-31 | $742,000 | −$14.6M | −95.16% |
| Q3 2023 | 2023-09-30 | $0 | −$3.4M | −100.00% |
| Q2 2023 | 2023-06-30 | $3.8M | −$5.3M | −58.05% |
| Q1 2023 | 2023-03-31 | $7.0M | −$564,000 | −7.44% |
| Q4 2022 | 2022-12-31 | $15.3M | $5.9M | +62.05% |
| Q3 2022 | 2022-09-30 | $3.4M | $2.3M | +204.81% |
| Q2 2022 | 2022-06-30 | $9.1M | $418,000 | +4.81% |
| Q1 2022 | 2022-03-31 | $7.6M | −$2.6M | −25.20% |
| Q4 2021 | 2021-12-31 | $9.5M | $709,000 | +8.10% |
| Q3 2021 | 2021-09-30 | $1.1M | −$11.6M | −91.30% |
| Q2 2021 | 2021-06-30 | $8.7M | −$1.3M | −13.24% |
| Q1 2021 | 2021-03-31 | $10.1M | −$1.4M | −12.26% |
| Q4 2020 | 2020-12-31 | $8.8M | −$3.3M | −27.61% |
| Q3 2020 | 2020-09-30 | $12.7M | $155,000 | +1.24% |
| Q2 2020 | 2020-06-30 | $10.0M | −$2.3M | −18.37% |
| Q1 2020 | 2020-03-31 | $11.5M | −$1.6M | −12.30% |
| Q4 2019 | 2019-12-31 | $12.1M | — | — |
| Q3 2019 | 2019-09-30 | $12.5M | — | — |
| Q2 2019 | 2019-06-30 | $12.3M | — | — |
| Q1 2019 | 2019-03-31 | $13.2M | — | — |
Revolution Medicines revenue growth trends
Revolution Medicines's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Revolution Medicines source filings ↗